The Society for Immunotherapy of Cancer (SITC) hosted Sessions 200 and 201 during the 39th Annual Meeting & Pre-Conference Programs on Saturday, November 9, 2024. Available here are the presentation slides and video from “Session 200: SITC Business Meeting” and "Session 201: Organizer Welcome" as permitted by presenters.
Leisha Emens, MD, PhD – Ankyra Therapeutics
Harriet Kluger, MD – Yale University
Join SITC President Leisha Emens, MD, PhD, and SITC Executive Director, Mary Dean, JD, CAE, for this annual briefing on Saturday, Nov. 9 from 7:15–7:45 a.m. CST. Dr. Emens and her guests Daniel S. Chen, MD, PhD and Stefani Spranger, PhD, will update you about the strategic direction of the society, including SITC’s Immuno-Engineering Strategic Plan: Engineering a path to 100 novel IO agents. All SITC members are invited to attend!
The official start of the second full day begins with a welcome from one of the Organizers behind the Annual Meeting programming.
To view the entire program schedule (including presenter permission to post) please click here.
00:04:45
00:24:52